Sensitivity difference to the suppressive effect of prostaglandin E2 among mouse strains: A possible mechanism to polarize Th2 type response in BALB/c mice

Journal of Immunology

Volumn 164, Issue 5, 2000, Pages 2386-2395

  Kuroda, Etsushi ^a   Sugiura, Tsutomu ^a   Zeki, Kazuya ^a   Yoshida, Yasuhiro ^a   Yamashita, Uki ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; GAMMA INTERFERON; INDOMETACIN; INTERLEUKIN 12; INTERLEUKIN 4; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E2;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; IMMUNOSTIMULATION; INTERFERON PRODUCTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; SPLEEN CELL; STAPHYLOCOCCUS AUREUS; STRAIN DIFFERENCE; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL;

EID: 0034163578     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.5.2386     Document Type: Article

References (49)

1. Mosmann, T. R., and R. L. Coffman. 1989. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145.
2. + T cell responses: the alternative approaches. Annu. Rev. Immunol. 15:297.
3. O'Garra, A. 1998. Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity 8:275.
4. + T cells. I. Influence of antigen concentration and antigen-presenting cell type. J. Exp. Med. 149:3468.
5. Pfeiffer, C., J. Stein, S. Southwood, H. Ketelaar, A. Sette, and K. Bottomly. 1995. Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo. J. Exp. Med. 181:1569.
6. 2-microglobulin-deficient BALB/c mice. J. Exp. Med. 183:485.
7. Kuchroo, V. K., M. P. Das, J. A. Brown, A. M. Ranger, S. S. Zamvil, R. A. Sobel, H. L. Weiner, N. Nabavi, and L. H. Glimcher. 1995. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 80:707.
8. + T cells to produce IL-4. J. Immunol. 158:4171.
9. Reiner, S. L., and R. M. Locksley. 1995. The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 13:151.
10. Scott, P., and T. Scharton. 1994. Interaction between the innate and the acquired immune system following infection of different mouse strains with Leishmania major. Ann. NY Acad. Sci. 730:84.
11. + T cells in BALB/c mice infected with Leishmania major instructs Th2 cell development and susceptibility to infection. Immunity 6:541.
12. + T cells resulting in a state of unresponsiveness to IL-12. J. Immunol. 161:6156.
13. Hoft, D. F., R. G. Lynch, and L. V. Kirchhoff. 1993. Kinetic analysis of antigen-specific immune responses in resistant and susceptible mice during infection with Trypanosoma cruzi. J. Immunol. 151:7038.
14. Huygen, K., D. Abramowicz, P. Vandenbussche, F. Jacobs, J. D. Bruyn, A. Kentos, A. Drowart, J. P. V. Vooren, and M. Goldman. 1992. Spleen cell cytokine secretion in Mycobacterium bovis BCG-infected mice. Infect. Immun. 60:2880.
15. Autenrieth, I. B., M. Beer, E. Bohn, S. H. E. Kaufmann, and J. Heesemann. 1994. Immune responses to Yersinia enterocolitica in susceptible BALB/c and resistant C57BL/6 mice: an essential role for γ interferon. Infect. Immun. 62:2590.
16. + T cells. J. Immunol. 156:1458.
17. Bohn, E., A. Sing, R. Zumbihl, C. Bielfeldt, H. Okamura, M. Kurimoto, J. Heesemann, and I. B. Autenrieth. 1998. IL-18 (IFN-γ-inducing factor) regulates early cytokine production in, and promotes resolution of, bacterial infection in mice. J. Immunol. 160:299.
18. Pope, M., S. W. Chung, T. Mosmann, J. L. Leibowitz, R. M. Gorczynski, and G. A. Levy. 1996. Resistance of naive mice to murine hepatitis virus strain 3 requires development of a Th1, but not Th2, response, whereas pre-existing antibody partially protects against primary infection. J. Immunol. 156:3342.
19. + T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol. Today 16: 34.
20. Trembleau, S., T. Germann, M. K. Gately, and L. Adorini. 1995. The role of IL-12 in the induction of organ-specific autoimmune diseases. Immunol. Today 16:383.
21. Kitching, A. R., P. G. Tipping, and S. R. Holdsworth. 1999. IL-12 directs severe renal injury, crescent formation and Th1 responses in murine glomerulonephritis. Eur. J. Immunol. 29:1.
22. Tanaka, Y., A. Takahashi, K. Watanabe, K. Takayama, T. Yahata, S. Habu, and T. Nishimura. 1996. A pivotal role of IL-12 in Th1-dependent mouse liver injury. Int. Immunol. 8:569.
23. H1 cell development. Science 271:984.
24. Phipps, R. P., S. H. Stein, and R. L. Roper. 1991. A new view of prostaglandin E regulation of the immune response. Immunol. Today 12:349.
25. 2 differentially modulate cytokine secretion profiles of human T helper lymphocytes. J. Immunol. 150:5321.
26. + T cells inhibits acquisition of ability to produce IFN-γ and IL-2, but not IL-4 and IL-5. J. Immunol. 155:4604.
27. 2 and dexamethasone inhibit IL-12 receptor expression and IL-12 responsiveness. J. Immunol. 161:2723.
28. 2 is a potent inhibitor of human interleukin 12 production. J. Exp. Med. 181:775.
29. 4 subtypes regulate activation and differentiation of mouse B lymphocytes to IgE-secreting cells. Proc. Natl. Acad. Sci. USA 93:10978.
30. + T cells. J. Immunol. 156:1722.
31. Yamashita, U., and T. Hamaoka, 1979. The requirement of Ia-positive accessory cells for the induction of hapten-reactive cytotoxic T lymphocytes in vitro. J. Immunol. 123:2637.
32. 2 receptors on human peripheral blood monocytes. Scand. J. Immunol. 21:167.
33. Zar, J. H. 1974. Biostatistical Analysis. Prentice Hall, Eaglewood Cliffs.
34. Bogdan, C., and C. Nathan. 1993. Modulation of macrophage function by transforming growth factor β, interleukin-4, and interleukin-10. Ann. NY Acad. Sci. 685:713.
35. Huang, F. P., W. Niedbala, X. Q. Wei, D. Xu, G. J. Feng, J. H. Robinson, C. Lam, and F. Y. Liew. 1998. Nitric oxide regulates Th1 cell development through the inhibition of IL-12 synthesis by macrophages. Eur. J. Immunol. 28:4062.
36. Muraille, E., and O. Leo. 1998. Revisiting the Th1/Th2 paradigm. Scand. J. Immunol. 47:1.
37. + cells and eosinophils in Nippostrongylus brasiliensis infection in resistant and susceptible strains of mice. Eur. J. Immunol. 26:2133.
38. Szabo, S. J., A. S. Dighe, U. Gubler, and K. M. Murphy. 1997. Regulation of the interleukin (IL)-12R β2 subunit expression in developing T helper 1 (Th1) and Th2 cells. J. Exp. Med. 185:817.
39. Rogge, L., L. Barberis-Maino, M. Biffi, N. Passini, D. H. Presky, U. Gubler, and F. Sinigaglia. 1997. Selective expression of an interleukin-12 receptor component by human T helper 1 cells. J. Exp. Med. 5:825.
40. Wu, C. Y., R. R. Warrier, X. Wang, D. H. Presky, and M. K. Gately. 1997. Regulation of interleukin-12 receptor β1 chain expression and IL-12 binding by human peripheral blood mononuclear cells. Eur. J. Immunol. 27:147.
41. Gollob, J. A., H. Kawasaki, and J. Ritz. 1997. Interferon-γ and interleukin-4 regulate T cell interleukin-12 responsiveness through the differential modulation of high-affinity interleukin-12 receptor expression. Eur. J. Immunol 27:647.
42. Maruo, S., M. Oh-hora, H. J. Ahn, S. Ono, M. Wysocka, Y. Kaneko, H. Yagita., K. Okumura, H. Kikutani, T. Kishimoto, M. Kobayashi, et al. 1997. B cells regulate CD40 ligand-induced IL-12 production in antigen-presenting cells (APC) during T cell/APC interaction. J. Immunol. 158:120.
43. Yoshida, A., Y. Koide, M. Uchijima, and T. O. Yoshida. 1995. Dissection of strain difference in acquired protective immunity against Mycobacterium bovis Calmette-Guérin Bacillus (BCG). J. Immunol. 155:2057.
44. + lymphocytes. J. Immunol. 158:5589.
45. + lymphocytes by inhibiting IL-12 production. J. Immunol. 160:2231.
46. 2, promote type 2 cytokine production in maturing human naive T helper cells. J. Immunol. 1997:28.
47. Hsieh, C. S., A. B. Heimberger, J. S. Gold, A. O'Garra, and K. M. Murphy. 1992. Differential regulation of T helper phenotype development by interleukin 4 and 10 in an αβ T-cell-receptor transgenic system. Proc. Natl. Acad. Sci. USA 89:6065.
48. 2. J. Immunol. 180:2365
49. Hwang, O. 1989. Essential fatty acids and immune response. FASEB J. 3:2052.